Efficacy and Safety of Intranasal Glucagon for Treatment of Insulin Induced Hypoglycemia in Adults with Diabetes

Conditions

Diabetes Mellitus, Type 1 | Diabetes Mellitus, Type 2

What is the purpose of this trial?

The primary objective of this study is to assess the effectiveness and safety of 3 mg glucagon (AMG504-1) administered as a puff into the nose compared with commercially-available glucagon given by injection.


Participation Guidelines

Age:
18 Years - 64 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Jaeb Center for Health Research
Dates:
12/02/2013
Last Updated:
Study HIC#:
1307012447